Financials data is unavailable for this security.
View more
Year on year ImmuPharma PLC had revenues fall -100.00% from 118.35k to 0.00, though the company grew net income from a loss of 8.17m to a smaller loss of 3.81m.
Gross margin | -- |
---|---|
Net profit margin | -4,275.31% |
Operating margin | -3,799.10% |
Return on assets | -97.05% |
---|---|
Return on equity | -159.35% |
Return on investment | -159.35% |
More ▼
Cash flow in GBPView more
In 2022, cash reserves at ImmuPharma PLC fell by 981.56k. Cash Flow from Financing totalled 1.55m or -- of revenues. In addition the company used 2.35m for operations while cash used for investing totalled 77.42k.
Cash flow per share | -0.0087 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0052 |
---|---|
Tangible book value per share | 0.0038 |
More ▼
Balance sheet in GBPView more
Current ratio | 1.17 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼